Overview

Seroquel for Frequent, Heavy Drinkers

Status:
Completed

Trial end date:
2014-01-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to examine the effects of quetiapine in reducing percent heavy drinking days and increasing percent abstinent days in alcohol dependent patients who are frequent heavy drinkers.

Phase:

Phase 2

Details

Lead Sponsor:

University of Pennsylvania

Collaborator:

National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Treatments:

Quetiapine Fumarate